Nephros (NEPH) EV to CFO (2010 - 2026)
Nephros (NEPH) posted EV to CFO of 50.03 for Q2 2026, up 395.48% on a QoQ basis from 16.93 in Q1 2026, and up 29.91% year-over-year from 38.51 in Q2 2025.
Powered by 
Analysis
Nephros (NEPH) EV to CFO (2010 - 2026) Analysis & Trends
Nephros has reported EV to CFO for 17 years, with the latest figure at 50.03 in Q2 2026.
- On a quarterly basis, EV to CFO rose 29.91% year-over-year to 50.03 in Q2 2026; TTM through Jun 2026 was 48.26, a 351.76% decrease from a year earlier, with the FY2025 full-year figure at 29.09, up 221.9% from the prior year.
- EV to CFO was 50.03 for Q2 2026 at Nephros, up from 16.93 in the prior quarter.
- The five-year high for EV to CFO was 455.49 in Q3 2025, with the low at 117.85 in Q4 2023.
- Average EV to CFO over 5 years is 31.78, with a median of 2.43 recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: EV to CFO slumped 237.2% in 2024, then surged 2694.32% in 2025.
- Over 5 years, EV to CFO stood at 59.33 in 2022, then sank by 98.65% to 117.85 in 2023, then soared by 107.64% to 9.0 in 2024, then soared by 2694.32% to 251.59 in 2025, then plunged by 80.11% to 50.03 in 2026.
- The last three EV to CFO figures came in at 50.03 (Q2 2026), 16.93 (Q1 2026), and 251.59 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.03 |
| Mar 31, 2026 | -16.93 |
| Dec 31, 2025 | 251.59 |
| Sep 30, 2025 | 455.49 |
| Jun 30, 2025 | 38.51 |
| Mar 31, 2025 | 43.95 |
| Dec 31, 2024 | 9.00 |
| Sep 30, 2024 | -25.00 |
| Jun 30, 2024 | -38.26 |
| Mar 31, 2024 | -28.96 |
| Dec 31, 2023 | -117.85 |
| Sep 30, 2023 | 18.22 |
| Jun 30, 2023 | 53.95 |
| Mar 31, 2023 | 26.75 |
| Dec 31, 2022 | -59.33 |
| Sep 30, 2022 | -51.27 |
| Jun 30, 2022 | -13.87 |
| Mar 31, 2022 | -24.05 |
| Dec 31, 2021 | -168.97 |
| Sep 30, 2021 | -93.90 |